joimax Reports Another Record In Revenues Globally In Q3/2017 And Introduces New Products At EUROSPINE In Dublin, Ireland And At NASS In Orlando, Florida

Published: Oct 10, 2017

IRVINE, Calif.--(BUSINESS WIRE)--Due to the fast growing user interest, but moreover the patient demand for endoscopic spinal surgery, joimax® sees another record in revenues in Q3/2017, with almost 60% of growth year over year, whereas joimax USA is almost doubling its revenues compared to 2016. “These results are also reflected in the huge interest at the SMISS Annual Forum which took place Sept 14- 16, 2017 in Las Vegas and the ISASS MIS Couse which took place Sept 22 – 23 in Long Beach, where joimax® as market leader supported the cadaveric lab sessions,” explains Wolfgang Ries, Founder and CEO of joimax®. Key presenters at these meetings had been Albert Telfeian, MD, PhD, Brown Univ., RI and Jian Shen, MD, PhD, Nathan-Lattauer Hospital, NY, both excellent surgeons with great experience.

Now at EUROSPINE, taking place Oct 11 – 13 in Dublin, Ireland, joimax® will introduce its new Shrill® Deflector Blades for spinal decompression. By deflecting, the blades provide an outstanding work-around-the-corner technology. They are applicable for the various joimax® TESSYS® systems as well as for the fast adopting iLESSYS® Delta system.

Additionally, a range of new Vaporflex® bipolar forceps for TESSYS® and iLESSYS® applications will be introduced as well. Those instruments are available in two handle versions and equipped with three different electrodes. The product portfolio will be completed by new sets of bipolar tweezers for micro surgery. All these bipolar instruments can be used with the very successful globally launched Endovapor® RF/HF generator, which received FDA clearance in April 2017 as well. joimax® underlines its market leadership with a professional trade fair appearance with Meet-the-Expert sessions at the booth and by hosting a Faculty and Distributor meeting prior to the conference in Dublin.

At NASS, for the first time ever, a full endoscopic spinal surgery session is included in the main program, held on October 26th in room WF3. The session is followed by an onsite cadaveric lab running from 5:10 PM – 8:00 PM with a full joimax® presence. In order to share the vast growing endoscopic user experience more widely, joimax® will hold a Meet-the-Expert presentations at the booth as well.

joimax® will wrap up its presence at NASS congress with an Expert meeting, including a wet lab, aiming to coordinate all training and education activities, specifically those which are related to US market needs.

About joimax®

Founded in Karlsruhe, Germany, in 2001, joimax® is the leading developer and marketer of complete systems for endoscopic minimally invasive spinal surgery. With TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression procedures, MultiZYTE® (for facet and sacroiliac joint therapy) or with EndoLIF® and Percusys® for minimally-invasive endoscopic assisted stabilizations, proven endoscopic systems are provided that, together, cover a variety of indications.

In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax® technologies to operate through small incisions - under local or full anesthetic - via tissue and muscle-sparing corridors through natural openings into the spinal canal (e.g. intervertebral foramen, the “Kambin triangle”).

Press contact USA:
joimax® Inc.
Melissa Brumley
Phone +1 949 859 3472
Melissa.brumley@joimaxusa.com

Back to news